TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Ebba Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,243
|
994
|
845 |
Financial expenses |
13
|
11
|
17 |
Earnings before taxes |
-1,212
|
-2,271
|
-2,010 |
EBITDA |
-1,158
|
-2,223
|
-1,949 |
Total assets |
822
|
1,201
|
1,111 |
Current assets |
723
|
1,081
|
936 |
Current liabilities |
296
|
541
|
176 |
Equity capital |
190
|
392
|
353 |
- share capital |
42
![]() |
42
|
46 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
23.1%
|
32.6%
|
31.8% |
Turnover per employee |
311
|
248
|
282 |
Profit as a percentage of turnover |
-97.5%
|
-228.5%
|
-237.9% |
Return on assets (ROA) |
-145.9%
|
-188.2%
|
-179.4% |
Current ratio |
244.3%
|
199.8%
|
531.8% |
Return on equity (ROE) |
-637.9%
|
-579.3%
|
-569.4% |
Change turnover |
244
|
217
|
441 |
Change turnover % |
24%
|
28%
|
109% |
Chg. No. of employees |
0
|
1
|
2 |
Chg. No. of employees % |
0%
|
33%
|
200% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.